GalleryGallery
Biosimilar Insulin Business Investment Briefing
-
- 2021-07-07
▲ The Order of Biosimilar Insulin Business Investment Briefing
▲ Greetings and Q&A related to Biosimilar Insulin Business of Chairman Jun Yong Soo and Vice-Chairman Kwon Hyuk Jin
▲ Introduction of Dr. Sahib
UNDBIO CO., Ltd, which declared to develop and produce insulin, a diabetes treatment, for the first time in Korea. They held a "Biosimilar Insulin Business Investment Briefing" to attract investment in pharmaceutical business such as building factories and expanding research institutes.